DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longerterm
outcomes in depressed outpatients requiring one or several
treatment steps: A STAR*D report. Am J Psychiatry, 2006,
163:1905–1917.
Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal
neurogenesis for the behavioral effects of antidepressants.
Science, 2003, 301:805–809.
Schmidt HD, Duman RS. The role of neurotrophic factors in
adult hippocampal neurogenesis, antidepressant treatments
and animal models of depressive- like behavior. Behav
Pharmacol, 2007, 18:391–418.
Sen S, Duman R, Sanacora G. Serum brain- derived neurotrophic
factor, depression, and antidepressant medications:
Meta- analyses and implications. Biol Psychiatry, 2008, 64:
527–532.
Shelton RC. Cellular mechanisms in the vulnerability to depression
and response to antidepressants. Psychiatr Clin North Am,
2000, 23:713–729.
Shelton RC. Augmentation strategies to increase antidepressant
efficacy. J Clin Psychiatry, 2007, 68(Suppl 10):18–22.
Shelton RC, Lester N. SSRIs and newer antidepressants, In, APA
Textbook of Mood Disorders. APA Press, Washington, D.C., 2006.
Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during
antidepressant treatment. Am J Psychiatry, 2006, 163:41–47.
Suominen KH, Isometsa ET, Henriksson MM, et al. Inadequate
treatment for major depression both before and after attempted
suicide. Am J Psychiatry, 1998, 155:1778–1780.
Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake
inhibitors in psychiatric disorders: A comprehensive review.
Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27:85–102.
Witkin JM, Marek GJ, Johnson BG, Schoepp DD. Metabotropic
glutamate receptors in the control of mood disorders. CNS
Neurol Disord Drug Targets, 2007, 6:87–100.
Zarate CA Jr., Singh JB, Carlson PJ, et al. A randomized trial of
an N- methyl- D- aspartate antagonist in treatment- resistant
major depression. Arch Gen Psychiatry, 2006, 63:856–864.
Zhao Z, Baros AM, Zhang HT, et al. Norepinephrine transporter
regulation mediates the long- term behavioral effects of the
antidepressant desipramine. Neuropsychopharmacology, 2008,
33:3190–3200.
Zhao Z, Zhang HT, Bootzin E, et al. Association of changes in
norepinephrine and serotonin transporter expression with the
long- term behavioral effects of antidepressant drugs.
Neuropsychopharmacology, 2009, 34:1467–1481.
415
CHAPTER 15
DRUG THERAPY OF DEPRESSION AND ANXIETY DISORDERS